Evaluation of Rituximab Efficacy and Safety in Lymphoma

Clinical Trial

Offered by: Nemours Children's
Locations: Delaware Valley and Pensacola in Florida

Trial Name

Intergroup Trial for Children or Adolescents With B-Cell Non-Hodgkin Lymphoma (NHL) or Mature B-Cell Leukemia (B-AL): Evaluation of Rituximab Efficacy and Safety in High Risk Patients

What is the trial about?

To see if using rituximab in combination with the DA-EPOCH chemotherapy will result in improved treatment outcome for children with PMLBL.

Who can participate?

6 months to < 18 yrs of age.

What is involved?

Length of study is 5 months. In addition to standard NHL care, other tests performed include immune system recovery blood tests and PET scans.